Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Total Liabilities : ¥1,839 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Total Liabilities?

Hainan Huluwa Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥1,839 Mil.

Hainan Huluwa Pharmaceutical Group Co's quarterly Total Liabilities increased from Sep. 2023 (¥1,520.08 Mil) to Dec. 2023 (¥1,901.18 Mil) but then declined from Dec. 2023 (¥1,901.18 Mil) to Mar. 2024 (¥1,838.68 Mil).

Hainan Huluwa Pharmaceutical Group Co's annual Total Liabilities increased from Dec. 2021 (¥830.41 Mil) to Dec. 2022 (¥1,296.79 Mil) and increased from Dec. 2022 (¥1,296.79 Mil) to Dec. 2023 (¥1,901.18 Mil).

Hainan Huluwa Pharmaceutical Group Co Total Liabilities Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Total Liabilities Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

442.67

605.58

830.41

1,296.79

1,901.18

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,297.29	1,433.21	1,520.08	1,901.18	1,838.68

Hainan Huluwa Pharmaceutical Group Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hainan Huluwa Pharmaceutical Group Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1082.501	+	(739.499	+	79.175
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,901

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	3060.549	-	1159.373
	=	1,901

Hainan Huluwa Pharmaceutical Group Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1214.446	+	(545.493	+	78.739
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	1,839

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	3028.415	-	1189.737
	=	1,839

Hainan Huluwa Pharmaceutical Group Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300

Website

http://www.huluwayaoye.com

Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines